Vivus signs $300 mln deal with Auxilium for erectile dysfunction drug

Fri Oct 11, 2013 7:19am EDT

Oct 11 (Reuters) - Vivus Inc said it would market its erectile dysfunction drug, Stendra, in the United States and Canada with Auxilium Pharmaceuticals Inc.

Auxilium said the deal, worth up to $300 million, would add to its earnings in 2015.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.